Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  9,211 results for ""Adverse Drug Reaction Reporting Systems""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study.

  • Authors : Chen C; Department of Pharmacy, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen 361000, China.; Chen C

Subjects: Myocarditis*/Myocarditis*/Myocarditis*/epidemiology ; Myocarditis*/Myocarditis*/Myocarditis*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 May 30; Vol. 133, pp. 112022. Date of Electronic Publication: 2024 Apr 13.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

An innovative method to strengthen evidence for potential drug safety signals using Electronic Health Records.

  • Authors : Abedian Kalkhoran H; Department of Clinical Pharmacology and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands. .; Department of Pharmacy, Haga Teaching Hospital, The Hague, the Netherlands. .

Subjects: Electronic Health Records*/Electronic Health Records*/Electronic Health Records*/organization & administration ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/organization & administration ; Pharmacovigilance*

  • Source: Journal of medical systems [J Med Syst] 2024 May 16; Vol. 48 (1), pp. 51. Date of Electronic Publication: 2024 May 16.Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 7806056 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System.

  • Authors : Elsallab M; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA.; Cellular Immunotherapy Program, Mass General Cancer Center, and Department of Medicine, Harvard Medical School, Boston, MA.

Subjects: Neoplasms, Second Primary*/Neoplasms, Second Primary*/Neoplasms, Second Primary*/etiology ; Neoplasms, Second Primary*/Neoplasms, Second Primary*/Neoplasms, Second Primary*/therapy ; Neoplasms, Second Primary*/Neoplasms, Second Primary*/Neoplasms, Second Primary*/epidemiology

  • Source: Blood [Blood] 2024 May 16; Vol. 143 (20), pp. 2099-2105.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

Read More Add to Saved list
×
Academic Journal

Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.

  • Authors : Li Y; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.; Wang X

Subjects: Dibenzothiepins*/Dibenzothiepins*/Dibenzothiepins*/adverse effects ; Triazines*/Triazines*/Triazines*/adverse effects ; Oseltamivir*/Oseltamivir*/Oseltamivir*/adverse effects

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 May 09; Vol. 24 (1), pp. 446. Date of Electronic Publication: 2024 May 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Connect Read More Add to Saved list
×
Periodical

Adverse drug reactions going unreported.

Subjects: Adverse Drug Reaction Reporting Systems*; Animals ; United Kingdom/United Kingdom/United Kingdom/epidemiology

  • Source: The Veterinary record [Vet Rec] 2024 May 04; Vol. 194 (9), pp. 324.Publisher: Wiley Country of Publication: England NLM ID: 0031164 Publication Model: Print Cited Medium: Internet ISSN: 2042-7670 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

Time-to-onset Analysis of Rhabdomyolysis due to Different Proton Pump Inhibitors Using a Pharmacovigilance Database.

  • Authors : Ohyama K; Center for Experiential Pharmacy Practice, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan; .

Subjects: Proton Pump Inhibitors*/Proton Pump Inhibitors*/Proton Pump Inhibitors*/adverse effects ; Proton Pump Inhibitors*/Proton Pump Inhibitors*/Proton Pump Inhibitors*/administration & dosage ; Rhabdomyolysis*/Rhabdomyolysis*/Rhabdomyolysis*/chemically induced

  • Source: In vivo (Athens, Greece) [In Vivo] 2024 May-Jun; Vol. 38 (3), pp. 1285-1291.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Rising cases of drug-induced pulmonary fibrosis: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database, 2000-2022.

  • Authors : McCall KL; Department of Pharmacy Practice, Binghamton University School of Pharmacy & Pharmaceutical Sciences, Johnson City, New York, USA.; Hennig KR

Subjects: Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; United States Food and Drug Administration* ; Databases, Factual*/Databases, Factual*/Databases, Factual*/statistics & numerical data

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 May; Vol. 33 (5), pp. e5797.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database.

  • Authors : Kim HK; Department of Neurology, National Medical Center, Seoul, South Korea.; Jang KS

Subjects: Anticonvulsants*/Anticonvulsants*/Anticonvulsants*/adverse effects ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/epidemiology

  • Source: Epilepsy & behavior : E&B [Epilepsy Behav] 2024 May; Vol. 154, pp. 109784. Date of Electronic Publication: 2024 Apr 17.Publisher: Academic Press Country of Publication: United States NLM ID: 100892858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A real‑world pharmacovigilance study of FDA adverse event reporting system events for daratumumab.

  • Authors : Yun X; Department of Pharmacy, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.; Zhou Y

Subjects: Pharmacovigilance* ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/adverse effects

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 May; Vol. 23 (5), pp. 581-591. Date of Electronic Publication: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Discovering clinical drug-drug interactions with known pharmacokinetics mechanisms using spontaneous reporting systems and electronic health records.

  • Authors : Jeong E; Department of Biomedical Informatics, School of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.; Su Y

Subjects: Electronic Health Records* ; Drug Interactions* ; Adverse Drug Reaction Reporting Systems*

  • Source: Journal of biomedical informatics [J Biomed Inform] 2024 May; Vol. 153, pp. 104639. Date of Electronic Publication: 2024 Apr 06.Publisher: Elsevier Country of Publication: United States NLM ID: 100970413 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  9,211 results for ""Adverse Drug Reaction Reporting Systems""